Trials / Completed
CompletedNCT05705596
Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
Einfluss Des süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Vienna · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of this cross-over intervention study is to investigate the influence of the sweet-modulating substance hesperetin in combination with sucrose in comparison to an equally sweet-tasting sucrose-only solution on markers of energy metabolism.
Detailed description
The study is designed as a randomised cross-over intervention study with two arms. The aim is to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in combination with 50 mg/L of the polyphenol hesperetin, on time-dependent blood glucose fluctuations and ad libitum energy intake in metabolically healthy male volunteers. To investigate the underlying mechanisms, the individual appetite score, metabolic and hormonal responses to the interventions and circulating extracellular vesicles and their miRNA composition will be measured. In addition, the participants' individual thresholds for sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners, and their body composition will be recorded as potential influencing factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sucrose | 10% sucrose corresponding to a regular soft drink |
| DRUG | Hesperetin | increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution |
Timeline
- Start date
- 2023-01-31
- Primary completion
- 2023-06-30
- Completion
- 2023-11-15
- First posted
- 2023-01-31
- Last updated
- 2023-11-28
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT05705596. Inclusion in this directory is not an endorsement.